Menu

1 / 2

Acrivon Therapeutics, Inc. (ACRV) Discusses ACR-525 Acquisition and PKC Inhibitor Preclinical Program - Slideshow

All Articles on Seeking Alpha·3 days ago
#CFmX8Fdp
Reading 0:00
15s threshold

The following slide deck was published by Acrivon Therapeutics, Inc. in conjunction with this event.

Acrivon Therapeutics, Inc. (ACRV) Discusses ACR-525 Acquisition and PKC Inhibitor Preclinical Program - Slideshow

SA Transcripts

163.03K Followers

This article was written by

163.03K Followers

Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team